On November 10, Scitop Bio responded to investors’ concerns on the investor relations platform.
Investors: May I ask, after the company transferred a strain of probiotics to Mengniu, will Mengniu’s probiotics purchase drop in the future? Does it have any impact on the company’s future performance? Will Mengniu aim at producing its own bacterial powder?
Scitop Bio: Dear investors, our company transferred a probiotic strain to Mengniu Dairy in the third quarter, and the raw bacterial powder of the strain is still produced by the company. Thus, Mengniu Dairy is expected to continue purchasing from the company. (Source: sohu.com)